-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

506.P1.36 506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster I

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Rohtesh S. Mehta, MD, MPH, MS1, Rima M Saliba, Ph.D2*, Kai Cao, MS, MD3*, Indreshpal Kaur, PhD4*, Katayoun Rezvani, M.D., PhD2, Julianne Chen2*, Amanda Olson5*, Simrit Parmar, MD2, Nina Shah, MD2, David Marin, MD, DM, MSc2*, Amin M. Alousi, MD2, Chitra Hosing, MD2, Uday R. Popat, M.D.2, Partow Kebriaei, MD2, Richard E. Champlin, MD2, Ian K. McNiece, PhD6, Marcos De Lima, MD7, Donna Skerrett8*, Elizabeth Burke8*, Elizabeth J. Shpall, MD2 and Betul Oran, MD2

1Hematology Oncology Transplantation, University of Minnesota, Minneapolis, MN
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas M. D. Anderson Cancer Center, Houston, TX
5Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Hematology and Oncology, University Hospitals Seidman Cancer Center, Cleveland
8Mesoblast Ltd, Melbourne, Australia

Marilena Ciciarello, PhD1*, Giulia Corradi, PhD student1*, Carmen Baldazzi, PhD2*, Nicoletta Testoni, Professor1*, Roberto Massimo Lemoli, MD3, Michele Cavo4* and Antonio Curti, MD, PhD2*

1Institute of Hematology and Medical Oncology, Bologna, Italy
2University of Bologna, Bologna, Italy
3Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy
4Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy

Aya Fujishiro, MD1,2*, Yasuo Miura, MD, PhD1, Masaki Iwasa, MD1,2*, Sumie Fujii, MD1,3*, Akihiro Tamura, MD1*, Atsushi Sato, MD1*, Asumi Yokota, PhD1*, Noriko Sugino, MD3*, Hideyo Hirai, MD, PhD1, Akira Ando, MD, PhD2*, Tatsuo Ichinohe, MD, Ph.D4 and Taira Maekawa, MD, PhD1

1Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Kyoto, Japan
2Division of Gastroenterology and Hematology, Shiga University of Medical Science, Shiga, Japan
3Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
4Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

Gregoire Stik, PhD*, Simon Crequit*, Jennifer Durant*, Laurence Petit*, Pierre Charbord, MD*, Thierry Jaffredo, PhD* and Charles Durand, PhD*

IBPS/UMR7622/U1156, CNRS/INSERM/UPMC, Paris, France

Áine M. Prendergast, PhD1,2*, Andrea Kuck1,2*, Mieke Von Essen1,2* and Marieke A. G. Essers, PhD1,2

1Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany
2German Cancer Research Center (DKFZ), Heidelberg, Germany

Paola Vinci1*, Antonio Bastone2*, Silvia Schiarea3*, Erica Dander1*, Mario Salmona2*, Silvano Sozzani4*, Andrea Biondi, Prof, MD5 and Giovanna D'Amico1

1Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
2Dipartimento di Biochimica delle proteine, Istituto per le Ricerche Farmacologiche Mario Negri, Milano, Italy
3Dipartimento di Ambiente e Salute, Istituto per le Ricerche Farmacologiche Mario Negri, Milano, Italy
4Dipartimento di Patologia Generale e Immunologia, Università degli Studi di Brescia, Brescia, Italy
5Centro Ricerca Tettamanti, Clinica Pediatrica, Università Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy

Bijender Kumar, PhD1*, Mayra Garcia, PhD2*, Guido Marcucci, MD1* and Ching-Cheng Chen, PhD1

1Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
2Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA

Seon-Yeong Jeong1*, Jin-A Kim1* and Il-Hoan Oh, MD, PhD2

1Catholic High Performance Cell Therapy Center & Department of Medical Lifescience, The Catholic University of Korea, Seoul, South Korea
2Catholic High Performance Cell Therapy Center & Department of Medical Lifescience, The Catholic University of Korea, Medical School, Seoul, South Korea

Peter Ruvolo, PhD1, Yihua Qiu, MD2*, Vivian Ruvolo, MS3*, Rui-Yu Wang, MD, PhD2, Zhihong Zeng, MD3, Jared Burks, PhD3*, Rongqing Pan, MS3, Numsen Hail Jr., PhD4*, Teresa McQueen1*, Suk-Young Yoo5*, Steven M. Kornblau, MD2 and Michael Andreeff, MD, PhD2

1Section of Molecular Hematology & Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
3Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Section of Molecular Heamtology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Benjamin J. Frisch, PhD1*, Alexandra N. Goodman, BS1*, Rhonda J. Staversky, BS1*, Olga Bromberg, RN2*, Xiaolin Tu, PhD3*, Teresita M. Bellido, PhD3* and Laura M. Calvi, MD4

1Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
2University of Rochester Medical Center, Rochester, NY
3Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN
4James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

Heather A Himburg, PhD1*, Phuong L Doan, MD2, Xiao Yan1,3, Mamle Quarmyne, PhD1*, Liman Zhao1*, Evelyn Tran1*, Nelson J. Chao, MD2, Jeffrey Harris, PhD4* and John P Chute, MD1,5,6

1Division of Hematology/Oncology, Department of Medicine, UCLA, Los Angeles, CA
2Dept. of Medicine, Div. of Hematological Malignancies & Cellular Therapy, Duke University Medical Center, Durham, NC
3Department of Pharmacology and Cancer Biology, Duke University, Durham, NC
4Celgene, Summit, NJ
5CA Broad Center for Regenerative Medicine and Stem Cell Research, UCLA, Los Angeles, CA
6Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA

Saloomeh Mokhtari1, Evan Joseph Colletti, PhD2*, Chad Sanada, PhD3*, Zanetta S. Lamar, MD4, Paul J Simmons5, Anthony Atala, MD6*, Diane S Krause, MD, PhD7, Esmail D. Zanjani, PhD8, Christopher D Porada, PhD6 and Graca Almeida-Porada, MD, PhD1

1Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC
2Charles River Laboratories, Reno, NV
3Yale School of Medicine, New Haven, CT
4Department of Hemtology/Oncology, Wake Forest University Health Sciences, Winston-Salem, NC
5Center for Stem Cell Research, The Brown Foundation Institute of Molecular Medicine, Houston, TX
6Wake Forest Institute for Regenerative Medicine, Winston Salem, NC
7Laboratory Medicine, Yale University School of Medicine, New Haven, CT
8Animal Biotechnology/ MS 202, University of Nevada, Reno, Reno, NV

*signifies non-member of ASH